GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » E10

Orion Pharma (DHA:ORIONPHARM) E10 : BDT4.18 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Orion Pharma's adjusted earnings per share data for the three months ended in Dec. 2023 was BDT0.470. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is BDT4.18 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Orion Pharma's average E10 Growth Rate was -3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-02), Orion Pharma's current stock price is BDT63.90. Orion Pharma's E10 for the quarter that ended in Dec. 2023 was BDT4.18. Orion Pharma's Shiller PE Ratio of today is 15.29.

During the past 11 years, the highest Shiller PE Ratio of Orion Pharma was 31.22. The lowest was 15.46. And the median was 18.73.


Orion Pharma E10 Historical Data

The historical data trend for Orion Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma E10 Chart

Orion Pharma Annual Data
Trend Dec13 Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 4.25

Orion Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.35 4.31 4.25 4.23 4.18

Competitive Comparison of Orion Pharma's E10

For the Utilities - Independent Power Producers subindustry, Orion Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Pharma's Shiller PE Ratio Distribution in the Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Orion Pharma's Shiller PE Ratio falls into.



Orion Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Orion Pharma's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.47/129.4194*129.4194
=0.470

Current CPI (Dec. 2023) = 129.4194.

Orion Pharma Quarterly Data

per share eps CPI Adj_EPS
201403 1.630 99.695 2.116
201406 1.400 100.560 1.802
201409 0.770 100.428 0.992
201412 0.449 99.070 0.587
201503 1.410 99.621 1.832
201506 0.740 100.684 0.951
201509 0.730 100.392 0.941
201512 1.270 99.792 1.647
201603 0.330 100.470 0.425
201606 0.000 101.688 0.000
201609 1.170 101.861 1.487
201612 1.290 101.863 1.639
201703 0.560 102.862 0.705
201706 0.376 103.349 0.471
201709 1.100 104.136 1.367
201712 0.970 104.011 1.207
201803 0.690 105.290 0.848
201806 0.666 106.317 0.811
201809 0.980 106.507 1.191
201812 1.080 105.998 1.319
201903 0.950 107.251 1.146
201906 0.760 108.070 0.910
201909 1.170 108.329 1.398
201912 0.970 108.420 1.158
202003 0.950 108.902 1.129
202006 0.090 108.767 0.107
202009 0.820 109.815 0.966
202012 1.210 109.897 1.425
202103 0.950 111.754 1.100
202106 1.030 114.631 1.163
202109 0.300 115.734 0.335
202112 1.720 117.630 1.892
202203 1.050 121.301 1.120
202206 0.547 125.017 0.566
202209 0.720 125.227 0.744
202212 1.190 125.222 1.230
202303 0.530 127.348 0.539
202306 0.296 128.729 0.298
202309 0.760 129.860 0.757
202312 0.470 129.419 0.470

Add all the adjusted EPS together and divide 10 will get our e10.


Orion Pharma  (DHA:ORIONPHARM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Orion Pharma's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=63.90/4.18
=15.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Shiller P/E Ratio of Orion Pharma was 31.22. The lowest was 15.46. And the median was 18.73.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Orion Pharma E10 Related Terms

Thank you for viewing the detailed overview of Orion Pharma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Pharma (DHA:ORIONPHARM) Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon Industrial Area, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma (DHA:ORIONPHARM) Headlines

No Headlines